Biopar Delta-forte
Product Images NDC 64661-793

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Biopar Delta-forte (NDC 64661-793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jaymac Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Blistercard

Blistercard
Biopar'delta-FORTE is a prescription hematopoietic preparation for therapeutic use containing 1 NF Units of BI, 50 mcg of F-THE, Timg PteGlu=, and 7 mg of Me-THf, supplied as oval, annatto ("orangish-brown”) multiphasic softgels with imprint "7N3". Each carton contains 30 softgels in blister cards. The adult dose is one capsule daily, and it should only be used under the direct supervision of a physician. Patients with pernicious anemia should receive periodic examinations and laboratory studies. The product warning notes that some patients may not respond to the orally ingested intrinsic factor containing products. The product is not authorized for use except on the prescription of a physician. The product is manufactured and/or packaged in the USA/Canada.*
FDA Label Image

Carton1

Carton1
FDA Label Image

Carton2

Carton2
FDA Label Image

Carton3

Carton3
FDA Label Image

Carton4

Carton4
Biopar™ delta-FORTE is a hematopoietic preparation formulated to treat macrocytic anemia and prevent folate deficiency in patients aged 12 and above. The prescription medication is effective in lowering homocysteine levels in patients. The product contains cobalamin, formylfolate, reduced folic acid, and L-methylfolate among other functional excipients and excipients. The adult dose is one capsule pill, and the patient should receive Reticuloendothelial plasma count, cobalamin, and folate tests before treatment. The product is indicated for the treatment of pernicious anemia, and its use without direct supervision by a physician is dangerous. The functional excipients in the product include fish/krill/porcine intrinsic factor and soy. The drug is supplied in multivitamins with the imprint '73' and comes with 30 capsules.*
FDA Label Image

Carton5

Carton5
FDA Label Image

Packageinsert

Packageinsert
FDA Label Image

Pillimage

Pillimage

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.